Recent developments in human cytomegalovirus diagnosis.
Since the early 1990s, great efforts have been made in the field of human cytomegalovirus (HCMV) diagnosis. Besides HCMV diagnosis in immunosuppressed patients (solid organ transplant recipients, hematopoietic stem cell transplant patients and AIDS patients), diagnosis in connection with congenital HCMV infection is of great interest. This review focuses on the development and clinical utility of serological assays, as well as on virological tests (molecular and nonmolecular assays). Interpretation of these tests is strongly dependent on the patient group (solid organ transplant recipients and hematopoietic stem cell transplant patients) and whether the tests are used for screening, risk stratification or diagnosis. Furthermore, a better understanding of HCMV infection has led to new approaches in HCMV diagnosis and monitoring. Thus, assays for viral resistance testing and assays for monitoring the HCMV-specific cellular immune response are increasingly important for the guidance of antiviral therapy.
Halwachs-Baumann
Gabriele
G
Krankenhaus Steyr, Steyr, Austria. gabriele.halwachs-baumann@gespag.at
D012634:Bodily Secretions / Q000821:virology; D001826:Body Fluids / Q000821:virology; D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000150:complications / Q000151:congenital / Q000175:diagnosis* / Q000276:immunology; D004279:DNA, Viral / Q000032:analysis / Q000097:blood; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000032:analysis / Q000097:blood; D012698:Serologic Tests; D014180:Transplantation / Q000009:adverse effects
D004279:DNA, Viral; D012367:RNA, Viral